HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cytembena and cis-platinum in combination for advanced stage ovarian carcinoma treatment.

AuthorsA Cardone, A Tolino, C Di Serio, R Zarcone, G Borruto Caracciolo, S Ronsini
JournalClinical and experimental obstetrics & gynecology (Clin Exp Obstet Gynecol) Vol. 9 Issue 2 Pg. 84-94 ( 1982) ISSN: 0390-6663 [Print] Singapore
PMID6897625 (Publication Type: Journal Article)
Chemical References
  • Acrylates
  • Antineoplastic Agents
  • Doxorubicin
  • Cyclophosphamide
  • bromebric acid
  • Cisplatin
Topics
  • Acrylates (administration & dosage)
  • Antineoplastic Agents (administration & dosage)
  • Carcinoma (drug therapy)
  • Cisplatin (administration & dosage)
  • Cyclophosphamide (therapeutic use)
  • Cystadenocarcinoma (drug therapy)
  • Doxorubicin (therapeutic use)
  • Drug Therapy, Combination
  • Female
  • Humans
  • Ovarian Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: